The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease : Nature

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease : Nature

Alzheimer’s disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration. Antibody-based immunotherapy against Aβ to trigger its clearan...

Close